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Abstract - To develop the effective control method for fed-batch culture of cyclosporin A production, we chose fructose, 
L-valine and (NH4)2HPO4 as feeding nutrients and compared their productivities in relation to different concentrations. 
The feeding rate of three kinds of feeding materials was controlled to maintain the suitable residual concentration. The 
fed-batch fermentation results indicated that the optimal concentrations of fructose, L-valine and (NH4)2HPO4 were about 
20 g/L, 0.5 g/L and 0.6 g/L for cyclosporin A production, respectively. The cultivation of Beauveria nivea could produce 
cyclosporin A up to 6.2 g/L for 240 hrs through a continuous feeding-rate-controlled-batch process under the optimal 
feeding conditions.
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INTRODUCTION
Cyclosporin A is a cyclic 11-membered fungal pep-
tide  metabolite  which  is  widely  used  as  a  power-
ful  immunosuppressant  in  transplantation  surgery 
(Zhao et al., 1991). The organisms that are known to 
produce cyclosporin A include Tolypocladium infla-
tum, Fusarium solani and Neocosmospora uarinfecta 
(Aarino and Agathos 1989; Sawai et al., 1981; Naka-
jima et al., 1988). In particular, the strain Tolypocla-
dium inflatum was also formally defined as Beauve-
ria nivea. The biosynthesis of cyclosporin A and its 
analogues appears to proceed via a non-ribosomal 
mechanism involving the sequential activation of all 
11 amino acids, their N-methylation and eventual 
peptide formation, by a single multifunctional en-
zyme, cyclosporin synthetase. Although cyclosporin 
A could be produced by the fungal microorganism 
Beauveria nivea in the matter of submerged cultiva-
tion of solid-state fermentation, the productivity of 
cyclosporin A was lower than that in the submerged 
fermentation. The previous studies have also proved 
that the exogenous supplementation of amino ac-
ids  such  as  L-valine  or  L-leucine  and  the  carbon 
source during fermentation could significantly en-
hance the production of cyclosporin A in submerged 
fermentation(Agathos and Parekh 1990; Agathos et 
al., 1987). The production of cyclosporin A generally 
is carried out by submerged fermentation with batch 
fermentation or internal feeding batch fermentation. 
Although  the  internal  feeding  batch  fermentation 
has a high yield of cyclosporin A in contrast to batch 
fermentation, this pattern almost resulted in the un-
stable substrate concentration disrupting the biosyn-
thesis of cyclosporin A. However, so far there is no 
perfect defined continuous fed-batch process for the 
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production of cyclosporin A. In the present study, 
the fungal strain Beauveria nivea was performed to 
produce cyclosporin A as the matter of continuous 
fed-batch fermentation. 
MATERIALS AND METHODS
Microorganism and culture conditions
The microorganism Tolypocladium inflatum (lnc1), 
indicated as Beauveria nivea, was stored in the Ag-
ricultural Culture Collection of China (ACCC) as 
number of 31701.The spores were obtained from a 
PDA agar (tomato 200 g/L, glucose 20 g/L, pH na-
ture), and spore suspensions were prepared after 10 
days of cultivation and maintained in 50% glycerol at 
-80°C. The viability of the deep-frozen cultures was 
periodically controlled by plating them onto an ISP2 
agar (malt extract 10 g/L, yeast extract 4 g/L, glucose 
4g/L, agar 20 g/L, pH7.2), and then counting the col-
onies formed to confirm the spore viability.
Fed-batch cultivation conditions
The inoculum for the shake flask was prepared by 
transferring the spore suspension in a 500-mL Er-
lenmeyer flask containing 100 mL of seed medium 
(containing fructose 5 g/L, glucose 12 g/L, soybean 
powder 30 g/L, corn steep powder 10 g/L, pH 6.0), 
incubating on a rotary shaker at 27°C and 240 rpm 
for 40 h, and inoculating the seed medium into a 
seed tank at a 2% v/v ratio and cultivating under 
the same conditions as the shake flask culture. The 
cyclosporin A biosynthesis was then performed us-
ing a fermentation medium (containing fructose 100 
g/L, (NH4)2HPO4 20 g/L, NaNO3 5 g/L, KH2PO4 3 
g/L, KCl 0.2 g/L, MgSO4·5H20 0.7 g/L, pH 6.5) in a 
30 L stirred tank bioreactor (Biotech-2002, Shanghai 
Baoxing Bio-engineering Equipment Co., Ltd, Chi-
na) with a working volume of 20 L. The agitation and 
aeration  were  adjusted  according  to  the  dissolved 
oxygen concentration. The pH was adjusted by ad-
dition of liquid ammonia. Fermentation foam was 
suppressed by the addition of the antifoam reagent 
aminoalkyl polysiloxane.   
Biomass determination
A 10 mL sample of culture broth was centrifuged at 
5,000 rpm for 5 min and the mycelial biomass was 
washed twice with distilled water after the super-
natant was decanted. The centrifuged cell mass was 
transferred to a pre-weighed metal dish and dried at 
90°C to constant weight (dry cell weight: DCW).
Total carbohydrates determination
The  total  carbohydrates  were  determined  spectro-
photometrically according to the method of Dubios 
et al. (1956).  
Ammonia nitrogen determination
The  ammonia  nitrogen  of  the  fermentation  broth 
was  determined  spectrophotometrically  according 
to the method described by Xie et al. (2005). 
Recovery and analysis of cyclosporin A
Cyclosporin  A  was  extracted  from  the  culture 
broth  according  to  the  following  process  (Ly  et 
al. 2007): 10 ml of culture was treated with 30 ml 
acetone at 35°C, 200 rpm for 3 h. Thereafter, the 
samples were centrifuged at 5,000 rpm for 10 min 
to delete the precipitation. The suspension was fil-
tered using a micropore filter. The concentration 
of cyclosporin A was determined with the reverse 
phase C18 column by HPLC method (Ly and Mar-
garitis 2007). 5 ml of fermentation broth was treated 
to collect the biomass by centrifugation at the speed 
of 3000 rpm. The biomass was extracted in 5 x vol-
ume of methanol for 2 h at 30°C. The supernatant 
of the extracted sampler was performed to detect 
cyclosporin A. The HPLC conditions were 70/30 
(V/V) of acetonitrile and water as the mobile phase, 
205 nm of ultraviolet detective wavelength, 1.5 mL/
min of flow rate, 70°C of column temperature and 
20 µL of sample size. The cyclosporin A was identi-
fied and quantified based on the similarity of reten-
tion time with that of standard cyclosporin A which 
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L-valine determination
An HPLC method was chosen to analyze the resi-
due L-valine in the medium (Lange et al. 2003). The 
medium,  free  of  cells,  obtained  by  centrifugation 
for 5 min at 14,000 rpm was derivatized with dansyl 
chloride solution before being injected into a C18-
ODS reversed phase column, 4.6×250 mm (Waters, 
USA). The mobile phase consisted of 60/40 (v/v) of 
methanol/water, 0.6% (v/v) of glacial acetic acid and 
0.008% (v/v) of triethylamine. The constant flow rate 
was 2 ml/min and derivatized L-valine was detected 
with a UV detector at 254 nm. 
Kinetic analysis
Another method of analyzing the fed-batch fermen-
tation was by examining the variation of specific pro-
ductivity, qp, and of specific growth rate, μ. The specific 
productivity,  qp=dP/dt  1/X ( P=cyclosporin  A  con-
centration, X=biomass concentration, t=time), and μ 
were derived from time-course data of cell mass and 
cyclosporin A concentration using a graphic package 
(Origin 7.5, origin lab company, USA, 2008)
RESULTS AND DISCUSSION
Optimization of the initial fructose concentration
In order to switch the primary metabolism of Beau-
veria nivea to the phase of cyclosporin A production 
rapidly and smoothly in fed-batch fermentation, it 
was necessary to optimize the initial carbon source 
concentration. It was evident from our studies that 
carbon sources such as glucose and sucrose, which 
are highly favored for biomass production by Beau-
veria nivea, do not generally provide the physiologi-
cal state necessary for optimal secondary metabolite 
formation (data not shown). It was identified that 
fructose as carbon source had the advantages of im-
proving the production of cyclosporin A (Isaac et al., 
1990). Thus, fructose was selected as both the initial 
and feeding carbon source. The effects of the differ-
ent initial fructose concentration on the cyclosporin 
A production in batch fermentation were investigat-
ed in a 30 L tank bioreactor. The results shown in Ta-
ble 1 indicated that low or high initial fructose con-
centration had a negative effect on the cyclosporin 
A production. It was concluded that the lower dis-
solved oxygen concentration triggered by the large 
biomass in the conditions of higher initial fructose 
concentration was the most important factor for the 
weak production of cyclosporin A. These data further 
demonstrated that the initial fructose concentration 
of 60 g/L gave rise to the highest specific production 
rate of 1.21 mg cyclosporin A per g cell and specific 
consumption rate of 155.84 mg cyclosporin A per g 
fructose.
Fed-batch fermentation processes of cyclosporin  
A at different residual fructose concentrations
The  biosynthesis  of  cyclosporin  A  by  the  fungus 
Beauveria nivea took a longer period of about 10 
days in the submerged fermentation, so it was nec-
essary to carry out the fed-batch fermentation for 
high production of cyclosporin A. Only a few studies 
about cyclosporin A production by continuous fed-
batch fermentation have been reported. In this study, 
the  continuous  fed-batch  fermentation  processes 
with different residual fructose concentrations of 10 
g/L, 15 g/L, 20 g/L and 25 g/L were examined. The 
Table 1.  The comparison of Yp/x and Yp/s at the different fructose concentrations.
Initial fructose  
concentration (g/l)
Maximum 
DCW (g/l)
Final pH cyclosporin  A 
(g/l)
Total fructose  
consumption  (g)
Yp/x
(mg/g)
Yp/s
(mg/g)
20 18.6 5.6 1.6 1360 86.02 1.17
40 25.7 4.2 2.8 2620 108.95 1.07
60 30.8 3.6 4.8 3980 155.84 1.21
80 33.6 2.8 4.5 4340 133.93 1.04
100 38.3 2.5 3.9 4900 101.83 0.79
120 42.1 2.2 3.5 5260 83.14 0.67910 H. DONG  ET AL.
other  conditions  and  parameters,  including  nitro-
gen source and L-valine, were controlled in the same 
way. The process curves of different feeding condi-
tions shown in Fig. 1 indicated that a high residual 
fructose concentration over 20 g/L resulted in high 
biomass and low cyclosporin A production. 10 g/L of 
the residual fructose also led to poor cyclosporin A 
production. Furthermore, the data of kinetic analy-
sis shown in Fig. 2 revealed that the increase of the 
residual fructose concentration was accompanied by 
a rise in the specific growth rate of Beauveria nivea, 
and that the specific production rate of cyclosporin 
A  in  the  condition  of  high  residual  fructose  was 
higher than that with lower residual fructose. The 20 
g/L of residual fructose concentration was optimal, 
and had a relatively low specific growth rate and the 
maximum specific production rate. It was interest-
ing that the pH was maintained over 4.0 when the 
residual fructose concentration was controlled at 10 
g/L and 15 g/L. However, the suitable pH environ-
ment of cyclosporin A biosynthesis ranged from 3.0 
to 4.0, as reported by Agathos et al. (1986). It was 
Fig. 1. Kinetics of cyclosporin A fermentation in a 30 l-stirred 
bioreactor.  Residual  sugar/■;  DCW/●;  Residual  L-valine/▲; 
pH/□; Residual ammonium nitrogen/○; cyclosporin A/r. A, 
fructose controlled about 10 g/L; B, fructose controlled about 15 
g/L; C, fructose controlled about 20 g/L; D, fructose controlled 
about 25 g/L. The concentration of L-valine and (NH4)2PO4 were 
controlled about 1.5 g/L and 0.6 g/L in A-D fermentations, re-
spectively.
Fig. 2. Analysis of cell growth and cyclosporin A production ki-
netics on the control of different fructose concentration. µ, spe-
cific growth rate; qp, specific productivity.
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concluded that the control of feeding fructose gen-
erated the principal effects on the biomass and pH 
condition, and further influenced the cyclosporin A 
production.      
Fed-batch fermentation processes of cyclosporin  
A at the different residual ammonium  
nitrogen concentrations
It has been revealed by Margaritis and Chahal (1989) 
that when fructose was used as a carbon source, the 
medium containing (NH4)2HPO4 resulted in high cy-
closporin A production compared to other nitrogen 
sources such as urea, (NH4)2SO4 , NaNO3 and even 
both (NH4)2SO4 and KH2PO4 in medium. Although 
the mechanism of (NH4)2HPO4 promoting the cy-
closporin A production was unknown, it was still fa-
vorable as a feeding nitrogen source in this study. In 
this test the concentration of carbon source fructose 
was maintained at 20 g/L, and the different residual 
ammonium nitrogen contents, such as 0.3 g/L and 
1.0 g/L, were examined. The fed-batch fermentation 
processes under different ammonium conditions are 
presented in Fig. 3. The results demonstrated that the 
1.0 g/L nitrogen concentration obviously inhibited 
the production of cyclosporin A (Fig. 3B). The curves 
of kinetic analysis shown in Fig. 4 indicated that the 
optimal  (NH4)2HPO4  content  was  0.6  g/L,  which 
originated from the data of Fig. 1C and presented 
the maximum specific production of cyclosporin A 
and suitable specific growth rate. The changes of am-
monium nitrogen content had no significant influ-
ence on the biomass of Beauveria nivea and pH trace. 
This inhibition phenomenon might be caused by the 
lower activity of cyclosporin A synthetase in the en-
vironment of a high ammonium ion concentration. 
 Fed-batch fermentation processes of cyclosporin A at 
the different residual L-valine concentrations
The precursor role of L-valine as its concentra-
tion increased in the medium matched well with 
the findings obtained with L-leucine in bacitracin 
fermentation by B. licheniformis (Haavik and Ves-
sia 1978). In short, the constituent amino acids of 
the cyclosporin A molecule, such as L-valine and 
Fig. 3. Kinetics of cyclosporin A fermentation in 30 l-stirred bio-
reactor – control of the (NH4)2HPO4 content. Residual sugar/■; 
DCW/●; Residual L-valine/▲; pH/□; Residual ammonium ni-
trogen/○; cyclosporin A/r. A, (NH4)2HPO4 controlled about 0.3 
g/L; B, (NH4)2HPO4 controlled about 1 g/L.
Fig. 4. Analysis of cell growth and cyclosporin A production ki-
netics on the control of different (NH4)2HPO4 concentration. µ, 
specific growth rate; qp, specific productivity.        
       0.3 g/L;       0.6 g/L;      1.0 g/L.
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L-leucine, may affect the production of the drug 
by assuming one or more roles such as precursor, 
inducer  and/or  developmental  regulator.  Some 
amino acids are believed to act as inducers that 
must be added in the exponential growth phase in 
order  to  enhance  secondary-metabolite  produc-
tion  by  directing  cell  development  towards  the 
transcription  of  the  genes  concerned,  a  process 
that occurs during vegetative cell growth. Previ-
ous studies have reported that the addition of L-
valine and L-leucine could obviously promote the 
biosynthesis of cyclosporin A (Lee and Agathos 
1989). However, our studies indicated that L-leu-
cine had no distinct positive effect on cyclosporin 
A production as a precursor (data not shown). In 
this study it was found that the cyclosporin A titer 
continued to increase after cell growth ceased and 
exogenous L-valine was depleted, which was con-
sistant with the earlier findings (Balakrishnan and 
Pandey 1996). Therefore, the feed of L-valine was 
arranged at the last stage of logarithmic growth. It 
was assumed that an intermediate compound ac-
cumulated during exponential cell growth and was 
utilized to produce cyclosporin A after depletion 
of the internal substrate. Furthermore, we inves-
tigated at which level the residual L-valine con-
centration  should  be  maintained.  The  results  in 
Fig. 5 showed that the precursor L-valine had no 
positive function with its concentration increasing 
during the feeding process. When the residual L-
valine in the fermentation broth was maintained 
at the lower concentration of 0.5 g/L, it obviously 
promoted  cyclosporin  A  production.  However, 
when the concentration of L-valine rose to 1.5 g/L, 
the biomass of Beauveria nivea increased rapidly 
and the cyclosporin A production decreased sig-
nificantly. The kinetic analysis data clearly proved 
that the lower L-valine content had a lower spe-
cific growth rate and higher specific production 
rate as is shown in Fig. 6. The above results were 
consistent with the previous study showing that 
the addition of L-valine during the initial stage of 
Fig. 5. Kinetics of cyclosporin A fermentation in 30 l-stirred 
bioreactor on the control of different L-valine concentration. 
Residual sugar/■; DCW/●; Residual L-valine/▲; pH/□; Residual 
ammonium nitrogen/○; cyclosporin A/r. A, L-valine controlled 
about 0.5 g/L; B, L-valine controlled about 1.0 g/L.
Fig. 6. Analysis of cell growth and cyclosporin A production ki-
netics on the control of different L-valine concentration. µ, spe-
cific growth rate; qp, specific productivity.
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cell growth has a negative effect on cyclosporin A 
production, but results in somewhat increased cell 
growth (Agathos and Lee 1993). This suggests an 
incompatibility between the primary and second-
ary metabolic networks involved in cyclosporin A 
biosynthesis after addition of the amino acid.
In  conclusion,  many  previous  researches 
have  attempted  to  optimize  the  production  of 
cyclosporin  A  in  submerged  cultures  and  were 
mostly  concerned  about  medium  optimization 
and the pulsed addition of nutrients (El Enshasy 
et al., 2008; Abdel-Fattah et al., 2007). The present 
study focused on continuous fed-batch fermenta-
tion based on providing the carbon source, nitro-
gen source and the amino acid L-valine, which has 
not been done so far. In order to synthesize cy-
closporin A in abundance, the lower initial level 
and optimal continuous feeding concentration of 
fructose were determined. This study verifies that 
the carbon source control was the important factor 
influencing cyclosporin A production. As for the 
feed of nitrogen, the regulatory scale seemed to be 
larger than that of fructose and L-valine. However, 
the higher level of (NH4)2HPO4 over 1 g/L obvi-
ously hindered the production of cyclosporin A. 
The continuous addition of a lower level L-valine 
during the later stage of the fermentation had a 
stimulatory effect on cyclosporin A. That this not 
mediated through additional cellular growth was 
ruled  out  since  the  higher  level  L-valine  could 
promote cell mass and inhibited the production of 
cyclosporin A.  
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